Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
Highlights from a roundtable featuring cancer survivors and researchers discussing cancer disparities and persistent health inequities.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...